Trinity Partners, LLC

Trinity Partners, LLC Company Profile

THE SCOOP

Health care pros

Trinity Partners is one of the fastest growing consulting firms in the health care industry, but with just three offices and over 100 employees, it has managed to keep its boutique feel.  The Massachusetts-based firm has outposts, in New York City and San Francisco. 

Since its founding in 1996, Trinity has maintained a singular industry focus: advising life sciences companies on market strategy, brand tactics, forecasting, licensing and data analysis.  Its clients include pharmaceutical, biotech, diagnostics and medical device providers, ranging from small companies to members of the Fortune 100.  The firm's expertise spans all therapeutic areas, including oncology, autoimmune disease, central nervous system disorders, infectious diseases, cardiovascular health, metabolics, urology and gastrointestinal conditions.  And, like a doctor with a patient, the firm prides itself on not stopping at a mere diagnosis of whatever happens to be ailing a client-it is committed to finding and implementing solutions as well. 

What sets Trinity apart from the rest is its consultants' ability to devise long-term, big-picture visions-or "roadmaps"-for clients, backed by industry expertise, quantitative focus, thorough research and evidence-based insights.  Consultants combine strategic and technical services to add value and optimize solutions across all of a client company's practice areas.

Trinity's offerings are further strengthened by its primary market research and advanced analytics practices.  Both teams operate vertically as standalone groups, but they also support other strategic consulting efforts.  The PMR team offers "opportunity assessment" by conducting quantitative and qualitative research, with insights from key stakeholders.  This allows for customization and transparency in the analysis provided to clients.  The advanced analytics team, led by statistics PhD Dr. Fotios Kokkotos, delivers market data not generally available from other sources by creating validated models from large pools of information.

Founding fathers

President John E. Corcoran founded Trinity Partners in 1996, and has over 20 years of experience as a consultant to the pharmaceutical and biotechnology industries. A graduate of Harvard College, Northeastern University and the John F. Kennedy School of Government at Harvard, Corcoran's specialties are data management, commercialization strategy and analytics.  He is also the the co-founder and president of Trinity Pharma Solutions and AkutaLabs. The former is a data management and software development company, while the latter is a biotech communications software company. .

These days, the firm's consulting operation is headed up by managing partner, David B. Fitzhenry. Another Harvard grad, Fitzhenry has a long track record as a consulting leader in the biotech, pharmaceutical, and medical device industries. Fitzhenry's clients encompass a wide selection of organizations, including venture-backed startups, midÔÇÉcap life sciences organizations, and traditional big pharma and biotech organizations. Under his leadership, the firm reports that its consulting practice has achieved annual growth in excess of 20 percent.

Both Corcoran and Fitzhenry sit on the board of directors at the Sports Legacy Institute. Sports Legacy Institute's (SLI) mission is to investigate, educate, and raise awareness regarding health risks of contact sports. SLI considers brain trauma in sports to be a public health crisis.

IN THE NEWS

August 2013/October 2012

Trinity Presents at Forecasting Conferences - EyeforPharma & CBI 

Leslie Sandberg Orne, Partner, at Trinity presented on "Forecasting for New Product Launches" at EyeforPharma's Forecasting Excellence USA Summit, in Islin, NJ, on October 16th and 17th 2012. The  presentation focused on the importance of launch forecasting with relevance to internal and external stakeholders, recent launches that have given insight to new drivers behind uptake, how to improve accuracy in forecasting new product uptake, and examples of how to train your management to consider a range of possible outcomes.

Trinity Partners also participated in CBI's Annual Bio/Pharmaceutical Conference on Strategic Pipeline Planning & Portfolio Valuation Conference in Philadelphia, PA on August 15th & 16th 2013.

January 2013

Trinity's Leadership Team Promotes Three, High Performing Firm Leaders to Partner

Trinity Partners named three new partners to the firm: Neal Dunn, Ryan Million, Ph.D., and Herman Sanchez. All three partners have extensive backgrounds working in the life sciences industry, and they have significantly contributed to the firm's growth and success since joining the company. They, along with the leadership team, foster a challenging, supportive, and collaborative environment for the 100+ Trinity employees and three offices - Waltham, New York, and San Francisco.

February 2013

Trinity Presents Several Posters at ISPOR & ISPOR's European Congress

Trinity Partners presented five posters at the 18th International Society For Pharmacoeconomics and Outcomes Research (ISPOR) conference held May 18th -22nd in New Orleans, LA.  ISPOR is the industry's leading organization that promotes Health Economics and Outcomes Research. The posters analyzed the epidemiology, cost, and healthcare resource utilization associated with hepatitis C virus (HCV) infection.

Fotios Kokkotos, PhD, a Partner at Trinity, presented the poster, "Is There an Overuse of Computed Tomography (CT) Scanning of Patients in United States Hospitals? A Review of the Evidence," at ISPOR's 15th Annual European Congress. Dr. Kokkotos is one of just one hundred and twenty statisticians accredited by the American Statistical Association (ASA.) The accreditation is based on a number of factors including educational achievement, ethical standards, work experience, professional competence, and publications. 

February 2013 

Trinity Presents Poster at Preventive Medicine 2013

Trinity presented a poster at Preventive Medicine 2013, the annual meeting of the American College of Preventive Medicine, held February 20-23rd in Scottsdale, AZ.  Physicians, health professionals, health care organizations, government agencies, and others committed to disease prevention and health promotion gathered together to discuss research within four main areas: Population Health Practice, Clinical Preventive Medicine and Lifestyle Medicine Practice, Technology and Informatics, and Medical Quality.  The poster assessed the extent to which Non-valvular atrial fibrillation (NVAF) overlapped with other high-burden, chronic illnesses and its contribution to disease burden. 

May 2013 

Trinity Published in Nature Reviews Drug Discovery 

Trinity published an article in the April issue of Nature Reviews Drug Discovery on antibody-drug conjugates (ADCs).  The article covered the recent approvals of brentuximab vedotin (Adcetris; Seattle Genetics/Millennium Pharmaceuticals) and ado-trastuzumab emtansine (Kadcyla (T-DM1), and discussed the future of ADC development and related deal-making.  An article reviewing the current epigenetic drug pipeline, with an emphasis on deal-making and the expansion of epigenetic agents to a broader range of therapeutic areas was recently submitted to Nature Reviews Drug Discovery this month. Nature Reviews Drug Discovery is a journal with an emphasis on the development and discovery of new drugs.  

June 2013 

Trinity Participates in 30th J.P. Morgan Challenge & Trinity Employee Winner of Men's Title 

Trinity Partners participated in the 30th J.P. Morgan Challenge, held in the Boston Common on June 20th 2013. Trinity employee, Andrew Combs was named the winner of the men's title. Twelve thousand runners and 571 companies participated in the 3.5-mile race. Combs, a consultant at Trinity Partners, won the highly competitive race in 17:43. Along with Andrew, 20 Trinity employees from the Waltham based office participated in the J.P. Morgan Corporate Challenge. The Challenge raised money for The One Fund, Emerald Necklace Conservancy, and City Spotlights Summer Leadership Program.  

▲ Show Less▼ Show Full Description


Trinity Partners, LLC


230 Third Ave.
Waltham, MA 02451
Phone: (781) 577-6300
Fax: (781) 487-7301
www.trinitypartners.com

STATS


  • Employer Type: Private
  • President: John E. Corcoran
  • Managing Partner: David B. Fitzhenry
  • 2013 Employees: 118

  • Employment Contact

    www.trinitypartners.com/index.php/join-trinity/

    Email: careers@trinitypartners.com


  • Major Departments & Practices

    Brand Planning

    Corporate Strategy

    Licensing & Acquisition

    Market Analytics

    Pipeline & Portfolio Optimization

    Promotional Effectiveness

Major Office Locations

  • Waltham, MA (HQ)
  • New York, NY
    San Francisco, CA

Career Update Newsletter

Tips and tools to help you manage your ideal career.